Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Revumenib

Home DrugsRevumenib

Investigational

Small Molecule

Revumenib

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₃₂H₄₇FN₆O₄S
CAS Number: 2169919-21-3
UNII ID: LZ0M43NNF2

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

SALTS AND POLYMORPHIC FORMS OF REVUMENIB
EP 4801918 A2Applicant: SYNDAX PHARMACEUTICALS INCPriority: 2023
EP
WO
2 publications
一种SDNX-5613的合成方法及其中间体化合物
CN 118994033 BApplicant: 成都先导药物开发股份有限公司Priority: 2023
CN